Antifolate Resistance inPlasmodium falciparum:Multiple Origins and Identification of NoveldhfrAlleles
Author(s) -
Andrea M. McCollum,
Amanda Poe,
Mary J. Hamel,
Curtis S. Huber,
Zhiyong Zhou,
Ya Ping Shi,
Peter Ouma,
John Vulule,
Peter Bloland,
Laurence Slutsker,
John W. Barnwell,
Venkatachalam Udhayakumar,
Ananías A. Escalante
Publication year - 2006
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/504687
Subject(s) - plasmodium falciparum , allele , virology , biology , antifolate , identification (biology) , malaria , genetics , drug resistance , immunology , gene , chemotherapy , antimetabolite , botany
Sulfadoxine-pyrimethamine has been widely used as first-line therapy for uncomplicated malaria throughout sub-Saharan Africa. Recent studies conducted in Asia and Africa suggest the triple-mutant dhfr genotype (51I/59R/108N) may have been generated as a single event in Southeast Asia, with subsequent spread of the single lineage to the African continent, but this hypothesis needs further validation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom